Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valerie A Francescutti

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
The Journal of Surgical Research|June 22, 2021
Barriers to Referral for Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Identified Using a Tailoring Grid Methodology: Interviews with Stakeholders in New York StateValerie A Francescutti, Joseph J Skitzki, John M Kane, et al.
Annals of Surgical Oncology|December 1, 2016
Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume SurgeonsAllison H Maciver, Eisar Al-Sukhni, Jesus Esquivel, et al.
Annals of Surgical Oncology|August 12, 2021
Restrictive Intraoperative Fluid Rate is Associated with Improved Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyJune S Peng, Jessica LaPiano, Katy Wang, et al.
Surgical Oncology|March 11, 2019
Nonoperative management after neoadjuvant therapy for rectal cancer: A single institution experience over 5 yearsMatthew Strode, Rupen Shah, Patrick M Boland, et al.
Annals of Surgical Oncology|January 4, 2019
Characterizing the Patient Experience of CS/HIPEC Through In-Depth Interviews with Patients: Identification of Key Concepts in the Development of a Patient-Centered ProgramValerie A Francescutti, Allison H Maciver, Erika Stewart, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
The Journal of Surgical Research|June 22, 2021
Barriers to Referral for Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Identified Using a Tailoring Grid Methodology: Interviews with Stakeholders in New York StateValerie A Francescutti, Joseph J Skitzki, John M Kane, et al.
Annals of Surgical Oncology|December 1, 2016
Current Delivery of Hyperthermic Intraperitoneal Chemotherapy with Cytoreductive Surgery (CS/HIPEC) and Perioperative Practices: An International Survey of High-Volume SurgeonsAllison H Maciver, Eisar Al-Sukhni, Jesus Esquivel, et al.
Annals of Surgical Oncology|August 12, 2021
Restrictive Intraoperative Fluid Rate is Associated with Improved Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyJune S Peng, Jessica LaPiano, Katy Wang, et al.
Surgical Oncology|March 11, 2019
Nonoperative management after neoadjuvant therapy for rectal cancer: A single institution experience over 5 yearsMatthew Strode, Rupen Shah, Patrick M Boland, et al.
Annals of Surgical Oncology|January 4, 2019
Characterizing the Patient Experience of CS/HIPEC Through In-Depth Interviews with Patients: Identification of Key Concepts in the Development of a Patient-Centered ProgramValerie A Francescutti, Allison H Maciver, Erika Stewart, et al.
Pageof 1